Where is AlloVir headquartered?

AlloVir is located in Waltham, MA.

Who invested in AlloVir?

AlloVir has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for AlloVir?

AlloVir closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

allovir.com

AlloVir

AlloVir develops and commercializes novel cell therapies for the treatment of cancer and lyme diseases.

Business Model:

Revenue: $165k

Employees: 51-200

Geographic Data

Address: 1100 Winter Street

City: Waltham

State: MA

Zip: 02451

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$127M

Raised Total:

$286M

Social

Twitter

Crunchbase

Metrics

1,755,370Website Global Rank

13,042Website Monthly Traffic

Twitter Followers

Description

AlloVir develops and commercializes novel cell therapies for the treatment of cancer and lyme diseases.

Contact Phone:
+16174332605

Contact Email:

IPO Details

AlloVir went public on 7/30/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/30/2020

IPO Valuation:
$1B

Ticker Symbol:
ALVR

IPO Price:
$17/share

Amount Raised:
$276M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
5/2019	Series B	8	$120M	Fidelity Management and Research Company Leerink Partners Fidelity Management and Research Company Samsara BioCapital Redmile Group Invus Gilead Sciences F2 Ventures EcoR1 Capital Fidelity Management and Research Company Leerink Partners Fidelity Management and Research Company
7/2022	Post-IPO Equity		$0	EcoR1 Capital ElevateBio F2 Ventures Gilead Sciences GMT Capital Invus Kite Pharma Redmile Group EcoR1 Capital ElevateBio F2 Ventures Gilead Sciences GMT Capital Invus Kite Pharma Redmile Group
7/2020	IPO		$305.3M
8/2017	Grant	1	$9M	Cancer Prevention and Research Institute of Texas Cancer Prevention and Research Institute of Texas
5/2019	Series B		$121.3M	Fidelity Management and Research Company Gilead Sciences F2 Ventures Redmile Group Invus EcoR1 Capital Samsara BioCapital
9/2018	Venture Round		$30M
7/2022	Post-IPO Equity	8	$126.6M	EcoR1 Capital ElevateBio F2 Ventures Gilead Sciences GMT Capital Invus Kite Pharma Redmile Group

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details